Skip to main content
SpringerLink
Log in

Hypertension

Does antihypertensive treatment have long-term benefits?

  • News & Views
  • Published:

From Nature Reviews Cardiology

View current issue Sign up to alerts

Clinical trials of antihypertensive drugs typically last up to 5 years, but lifelong therapy for patients with hypertension is recommended in all treatment guidelines. To address this discrepancy, investigators from the Systolic Hypertension in the Elderly Program have published data from a 22-year follow-up showing sustained benefits of antihypertensive treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265, 3255–3264 (1991).

  2. Sutton-Tyrrell, K., Wildman, R., Newman, A. & Kuller, L. H. Extent of cardiovascular risk reduction associated with treatment of isolated systolic hypertension. Arch. Intern. Med. 163, 2728–2731 (2003).

    Article  Google Scholar 

  3. Kostis J. B. et al. Association between chlorthalidone treatment of systolic hypertension and long-term survival. JAMA 306, 2588–2593 (2011).

    Article  CAS  Google Scholar 

  4. Staessen, J. A. et al. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J. Hypertens. 22, 847–857 (2004).

    Article  CAS  Google Scholar 

  5. Beckett, N. et al. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ 344, d7541 (2011).

    Article  CAS  Google Scholar 

  6. Holman, R. R., Paul, S. K., Bethel, M. A., Neil, H. A. & Matthews, D. R. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N. Engl. J. Med. 359, 1565–1576 (2008).

    Article  CAS  Google Scholar 

  7. Multiple Risk Factor Intervention Trial Research Group. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 82, 1616–1628 (1990).

  8. Bosch, J. et al. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension. Circulation 112, 1339–1346 (2005).

    Article  Google Scholar 

  9. Sytkowski, P. A., D'Agostino, R., Belanger, A. & Kannel, W. B. Secular trends in long-term sustained hypertension, long-term treatment and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. Circulation 93, 697–703 (1996).

    Article  CAS  Google Scholar 

  10. Mancia, G. Antihypertensives in octogenarians. BMJ 344, d7293 (2012).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Medicine, University of Milano–Bicocca, Ospedale San Gerardo, Via Pergolesi, 33–20900, Monza, Italy

    Giuseppe Mancia

Authors
  1. Giuseppe Mancia
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mancia, G. Does antihypertensive treatment have long-term benefits?. Nat Rev Cardiol 9, 130–132 (2012). https://doi.org/10.1038/nrcardio.2012.11

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2012.11

  • Springer Nature Limited

Search

Navigation